Table 2.
Outcomes for screening strategies with similar age to start and age to stop screening as the selected benchmark colonoscopy strategy
| Modality, and Age to Start, Age to End, Interval (years) |
Outcomes per 1000 40-year-olds
|
Efficiency Ratiob |
ER < Benchmarkc |
LYG >= 90% of Benchmark |
Model- Recommended Strategyd |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of Stool tests |
No. of SIGs |
No. of CTCs |
No. of COLs |
LYG | Complications | CRC Deaths Averteda |
|||||
| Colonoscopy | |||||||||||
| COL 45-75-10e | 0 | 0 | 0 | 5646 | 429 | 23 | 37 | 32 | - | - | Yes |
|
| |||||||||||
| Stool tests | |||||||||||
| FIT 45-75-3 | 8038 | 0 | 0 | 1619 | 310 | 11 | 27 | 5 | Yes | No | |
|
| |||||||||||
| FIT 45-75-2 | 10973 | 0 | 0 | 1994 | 352 | 13 | 30 | 9 | Yes | No | |
|
| |||||||||||
| HSgFOBT 45-75-3 | 7405 | 0 | 0 | 2024 | 310 | 13 | 27 | Dom. | - | No | |
|
| |||||||||||
| FIT-DNA 45-75-5 | 4949 | 0 | 0 | 2157 | 333 | 14 | 29 | Dom. | - | No | |
|
| |||||||||||
| HSgFOBT 45-75-2 | 9776 | 0 | 0 | 2516 | 354 | 15 | 30 | Dom. | - | No | |
|
| |||||||||||
| FIT-DNA 45-75-3 | 6644 | 0 | 0 | 2640 | 376 | 16 | 32 | Dom | - | No | |
|
| |||||||||||
| FIT 45-75-1 | 17835 | 0 | 0 | 2698 | 403 | 16 | 34 | 14 | Yes | Yes | Yes |
|
| |||||||||||
| HSgFOBT 45-75-1 | 14366 | 0 | 0 | 3364 | 403 | 18 | 34 | Dom. | - | Yes | |
|
| |||||||||||
| FIT-DNA 45-75-1 | 12019 | 0 | 0 | 3851 | 426 | 19 | 36 | 50 | No | Yes | |
| Flexible sigmoidoscopy | |||||||||||
| SIG 45-75-10 | 0 | 2691 | 0 | 3314 | 373 | 19 | 33 | 9 | Yes | No | |
|
| |||||||||||
| SIG 45-75-5 | 0 | 3865 | 0 | 3761 | 403 | 20 | 35 | 15 | Yes | Yes | Yes |
|
| |||||||||||
| CT colonography | |||||||||||
| CTC 45-75-10 | 0 | 0 | 3045 | 2106 | 322 | 14 | 29 | 6 | Yes | No | |
|
| |||||||||||
| CTC 45-75-5 | 0 | 0 | 4630 | 2666 | 390 | 16 | 34 | 8 | Yes | Yes | Yes |
COL=colonoscopy, Dom.= Dominated, FIT= Fecal immunochemical test, HSgFOBT=High-sensitivity guaiac-based fecal occult blood test, FIT-DNA=Multitarget stool DNA test, SIG= Flexible sigmoidoscopy, CTC= Computed tomographic colonography, LYG= Life-years gained, CRC= Colorectal cancer, ER= Efficiency ratio
In the absence of screening, the model predicted 45 CRC Deaths.
calculated as . It is an incremental burden-to-benefits ratio.
A strategy can only be recommended by the model if it has an efficiency ratio lower than the efficiency ratio of the benchmark strategy (colonoscopy every 10 years from ages 45 to 75 years).
A strategy is recommended by the model if it is an efficient or a near-efficient strategy with a lower burden-to-benefits ratio and at least 90% of the LYG compared to the benchmark strategy (colonoscopy screening every 10 years from ages 45 to 75 years).
This strategy was selected by the model when an efficiency ratio threshold of 40 or 45 incremental colonoscopies per LYG was applied.